September 03, 2025

FDA Approves Denosumab Biosimilars

The FDA approved Bildyos and Bilprevda are providing new options comparable to Prolia and Xgeva for osteoporosis, cancer-related bone disease, and other skeletal conditions.

Conexiant

August 28, 2025

Late Dinners, Fragile Bones?

Fracture risk varies by site, with distal forearm outcomes diverging from hip, vertebral, and humeral patterns

Conexiant

August 26, 2025

Ancient Bones Tell Tales

Perhaps so-called modern diseases aren’t as new as we thought...

The Pathologist

August 22, 2025

New Recommendations Released for Managing Aromatase Inhibitor–Induced Bone Loss

A group of experts from seven professional societies have published a joint position statement in the Journal of Bone Oncology on the management of aromatase inhibitor–associated bone loss as a guide ...

The ASCO Post

August 22, 2025

Osteoporosis and AMD Risk

Study explores the link between osteoporosis and AMD with data taken from NHANES

The Ophthalmologist

August 18, 2025

Health Groups Respond to 'National Scandal'

With elder homelessness rising, PACE programs funded by Medicaid and Medicare secure housing and health care for low-income seniors, seen in Rhode Island.

KFF Health News

August 14, 2025

Low Bone Quality in RA Tied to Diabetes, Study Shows

Trabecular bone score identifies high rates of vertebral bone quality loss in women with rheumatoid arthritis, regardless of corticosteroid use.

Conexiant

August 14, 2025

Are Immigration Raids Sending Patients Online?

Clinics and health plans are expanding telehealth services as increased immigration enforcement has coincided with some patients, including immigrant families, delaying or avoiding in-person medical visits.

KFF Health News

August 11, 2025

Why Turning 26 Jeopardizes Health Coverage

A growing number of young Americans lose affordable health insurance at age 26, facing complex Affordable Care Act marketplaces, rising costs, and limited coverage options.

KFF Health News